Skip Nav Destination
Issues
1 December 2014
-
Cover Image
Cover Image
Donohoe and colleagues used a gnotobiotic mouse model colonized with bacteria that converts fiber into butyrate to show that a high-fiber diet does protect against colorectal tumorigenesis but that the effect is dependent on butyrate and the composition of the gut microbiota. Butyrate serves as the main mitochondrial energy source for normal colonocytes but accumulates in cancer cells, which are instead dependent on glucose due to increased glycolysis associated with the Warburg effect. Accumulation of butyrate, an endogenous histone deacetylase inhibitor, is associated with increased histone acetylation in colorectal tumors and increased expression of genes with known roles in apoptosis and cell-cycle arrest. These findings indicate that dietary fiber can protect against colorectal cancer and suggest that gut microbiome studies should be integrated with future epidemiologic studies on fiber and colorectal cancer risk. For details, please see the article by Donohoe and colleagues on page 1387. - PDF Icon PDF LinkTable of Contents
ISSN 2159-8274
EISSN 2159-8290
Issue Sections
In This Issue
In the Spotlight
Review
Research Briefs
A Gnotobiotic Mouse Model Demonstrates That Dietary Fiber Protects against Colorectal Tumorigenesis in a Microbiota- and Butyrate-Dependent Manner
Dallas R. Donohoe; Darcy Holley; Leonard B. Collins; Stephanie A. Montgomery; Alan C. Whitmore; Andrew Hillhouse; Kaitlin P. Curry; Sarah W. Renner; Alicia Greenwalt; Elizabeth P. Ryan; Virginia Godfrey; Mark T. Heise; Deborah S. Threadgill; Anna Han; James A. Swenberg; David W. Threadgill; Scott J. Bultman
Author Choice
Comprehensive Genomic Profiling of Pancreatic Acinar Cell Carcinomas Identifies Recurrent RAF Fusions and Frequent Inactivation of DNA Repair Genes
Juliann Chmielecki; Katherine E. Hutchinson; Garrett M. Frampton; Zachary R. Chalmers; Adrienne Johnson; Chanjuan Shi; Julia Elvin; Siraj M. Ali; Jeffrey S. Ross; Olca Basturk; Sohail Balasubramanian; Doron Lipson; Roman Yelensky; William Pao; Vincent A. Miller; David S. Klimstra; Philip J. Stephens
Research Articles
Mutation-Specific RAS Oncogenicity Explains NRAS Codon 61 Selection in Melanoma
Christin E. Burd; Wenjin Liu; Minh V. Huynh; Meriam A. Waqas; James E. Gillahan; Kelly S. Clark; Kailing Fu; Brit L. Martin; William R. Jeck; George P. Souroullas; David B. Darr; Daniel C. Zedek; Michael J. Miley; Bruce C. Baguley; Sharon L. Campbell; Norman E. Sharpless
PARP1-Driven Poly-ADP-Ribosylation Regulates BRCA1 Function in Homologous Recombination–Mediated DNA Repair
Yiduo Hu; Sarah A. Petit; Scott B. Ficarro; Kimberly J. Toomire; Anyong Xie; Elgene Lim; Shiliang A. Cao; Eunyoung Park; Michael J. Eck; Ralph Scully; Myles Brown; Jarrod A. Marto; David M. Livingston
Access to Follicular Dendritic Cells Is a Pivotal Step in Murine Chronic Lymphocytic Leukemia B-cell Activation and Proliferation
Kristina Heinig; Marcel Gätjen; Michael Grau; Vanessa Stache; Ioannis Anagnostopoulos; Kerstin Gerlach; Raluca A. Niesner; Zoltan Cseresnyes; Anja E. Hauser; Peter Lenz; Thomas Hehlgans; Robert Brink; Jörg Westermann; Bernd Dörken; Martin Lipp; Georg Lenz; Armin Rehm; Uta E. Höpken
News in Brief
Research Watch
Bladder Cancer
Chemotherapy
Clinical Trials
Colorectal Cancer
Drug Discovery
Drug Resistance
Epigenetics
Genomics
Glioblastoma
Hematologic Diseases
Immunology
Lymphoma
Metastasis
Mutations
Neuroblastoma
Pancreatic Cancer
Prostate Cancer
Sarcoma
Signaling
Targeted Therapy
Tumor Heterogeneity
Ubiquitination
Acknowledgment to Reviewers
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.